文章摘要

文章信息/Info

Title:: Application of anti-tachycardia pacing therapy of implantable cardioverter defibrillator in prevention of sudden cardiac death

作者:: 魏欣; 林涛; (首都医科大学附属北京天坛医院心内科，北京 100050)

Author(s):: WEI Xin; LIN Tao; (Department of Cardiology, Beijing Tiantan Hospital Affiliated Capital University of Medical Seiences, Beijing 100050, China)

关键词:: 植入型心律转复除颤器; 心脏性猝死; 无痛性治疗

Keywords:: implantable cardioverter defibrillator; sudden cardiac death; painless treatment

分类号:: R541

DOI:: -

文献标识码:: A

摘要:: 植入型心律转复除颤器（ICD）是预防心脏性猝死的最重要的手段。ICD的无痛性治疗又称抗心动过速起搏（ATP）治疗，是ICD终止室速的最重要治疗方法。如何在保证患者安全的前提下减少ICD放电．特别是减少不恰当放电，更好地应用ICD技术为患者服务，深入了解和掌握无痛性ATP治疗十分重要。本文就ICD无痛ATP治疗相关内容及进展进行综述。

Abstract:: Implantable cardioverter defibrillator (ICD) is the most important means of prevention of sudden cardiac death. ICD, a painless treatment also known as anti-tachycardia pacing (ATP) treatment, is the most important treatment for ICD termination of ventricular tachycardia. Ensuring the safety of patients and reducing ICD discharge, inappropriate discharge in particular, to better use ICD technology for patients is imperative. In this article we review related aspects and progress of ATP therapy in ICD.

参考文献/References

[1]Fukuda K,Kanazawa H,Aizawa Y,et al.Cardiac innervation and sudden cardiac death[J].Circ Res,2015,116(12):2005-2019.
[2]Francis J,Namboodiri N.Update on ventricular tachyarrhythmias and related sudden cardiac death[J].Indian Pacing Electrophysiol J,2014,14(6):316-319.
[3]Proietti R,Labos C,Davis M,et al.A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality[J].Can J Cardiol,2015,31(3):270-277.
[4]Kajanová A,Bulava A,Eisenberger M.Factors influencing psychological status and quality of life in patients with implantablecardioverter-defibrillators［J］. Neuro Endocrinol Lett,2014,35(Suppl 1):54-58.
[5]Huang DT,Traub D.Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy:a comprehensive review[J].Prog Cardiovasc Dis,2008,51(3):229-236.
[6]Sinha SK,Mehta D,Gomes JA.Prevention of sudden cardiac death:the role of the implantable cardioverter-defibrillator[J].Mt Sinai J Med,2005,72(1):1-9.
[7]Gracieux J,Sanders GD,Pokorney SD,et al.Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy:a systematic review[J].Int J Cardiol,2014,177(3):990-994.
[8]Trappe HJ,Klein H,Kielblock B.Role of antitachycardia pacing in patients with third generation cardioverter defibrillators[J].Pacing Clin Electrophysiol,1994,17(3 Pt 2):506-513.
[9]Shorofsky SR,Rashba E,Havel W,et al.Improved defibrillation efficacy with an ascending ramp waveform in humans[J].Heart Rhythm,2005,2(4):388-394.
[10]Watanabe T,Inoue K,Kashiwase K,et al.Efficacy of anti-tachycardia pacing for terminating fast ventricular tachycardia in Japanese implantable cardioverter defibrillator patients.Primary results of the SATISFACTION study[J].Circ J,2014,78(11):2643-2650.
[11]Ruwald AC,Schuger C,Moss AJ,et al.Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy(MADIT-RIT)[J].Circ Arrhythm Electrophysiol,2014,7(5):785-792.
[12]Friedman PA,Bradley D,Koestler C,et al.A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention[J].Europace,2014,16(10):1460-1468.
[13]Hügl B,Israel CW,Unterberg C,et al.Incremental programming of atrial anti-tachycardia pacing therapies in bradycardia-indicated patients:effects on therapy efficacy and atrial tachyarrhythmia burden[J].Europace,2003,5(4):403-409.
[14]Wathen MS,Sweeney MO,DeGroot PJ,et al.Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease[J].Circulation,2001,104(7):796-801.
[15]Wathen MS,DeGroot PJ,Sweeney MO,et al.Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators:Pacing Fast Ventricular Tachycardia Reduces Shock Therapies(PainFREE Rx II)trial results[J].Circulation,2004,110(17):2591-2596.
[16]Gulizia MM,Piraino L,Scherillo M,et al.A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial[J].Circ Arrhythm Electrophysiol,2009,2(2):146-153.
[17]Santini M,Lunati M,Defaye P,et al.Prospective multicenter randomized trial ventricular of fast tachycardia termination by prolonged versus conventional anti- tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients ATP Delivery for ICD painless therapy (ADVANCE-D)Trial results[J].J Interv Card Electrophysiol,2010,27(2):127-135.
[18]Zaman S,Sivagangabalan G,Chik W,et al.Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study[J].J Interv Card Electrophysiol,2014,41(3):195-202.
[19]Jiménez-Candil J,Anguera I,Ledesma C,et al.Morphology of far-field electrograms and antitachycardia pacing effectiveness among fastventricular tachycardias occurring in ICD patients:a multicenter study[J].J Cardiovasc Electrophysiol,2013,24(12):1375-1382.
[20]Martins RP,Blangy H,Muresan L,et al.Safety and efficacy of programming a high number of antitachycardia pacing attempts for fast ventricular tachycardia:a prospective study[J].Europace,2012,14(10):1457-1464.

我们的网站为什么显示成这样？

ICD的无痛治疗在心脏性猝死预防中的应用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics